Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion type Assertion NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_head.
- NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion description "[The novel approach used here led to the discovery that perhexiline ablates HER3 expression, and offers an opportunity to identify HER3 ablation modulators as innovative therapeutics to improve survival in breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_provenance.
- NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion evidence source_evidence_literature NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_provenance.
- NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion SIO_000772 25849870 NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_provenance.
- NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion wasDerivedFrom befree-2016 NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_provenance.
- NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_assertion wasGeneratedBy ECO_0000203 NP1276386.RAB_2tkdM-bAG0acK3-1yiPIGWgAb1Ng9rQYyrDXrTfTs130_provenance.